Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Available 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Sarcoma 2

Conditions

Osteosarcoma 2Neoplasms, Bone Tissue 1

Interventions

Cyclophosphamide 9X-Rays 8Specimen Handling 8Phantoms, Imaging 7fludarabine 6Magnetic Resonance Spectroscopy 6cabozantinib 5Gemcitabine 5Biopsy 5Nuclear Medicine Department, Hospital 4Methotrexate 4Doxorubicin 4fludarabine phosphate 3Ifosfamide 3Cisplatin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2pembrolizumab 2palbociclib 2olaparib 2mifamurtide 2larotrectinib 2ivosidenib 2irinotecan sucrosofate 2ensartinib 2atezolizumab 2Vincristine 2Temozolomide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Osteosarcoma × mifamurtide × 90 days × Clear all
NCT03643133 2026-05-19

SARCOME13

UNICANCER

Phase 2 Active not recruiting
60 enrolled
Sarcoma

Osteosarcoma, Neoplasms, Bone Tissue

NCT04571229 2026-05-11

Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma

Memorial Sloan Kettering Cancer Center

Available
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡